FDA Identifies Excipients At Risk for Potential Melamine Contamination; Issues Alert That New USP Standards for Heparin Products Will Result in Decreased Potency

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.